Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MIMEDX GROUP, INC.

(MDXG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

MiMedx : Amniotic Tissue Failed to Meet Primary Endpoints in Two Trials; Shares Plunge

09/13/2021 | 10:57am EDT


ę MT Newswires 2021
All news about MIMEDX GROUP, INC.
10/20MIMEDX : to Host Third Quarter 2021 Operating and Financial Results Conference Call on Nov..
AQ
10/14MIMEDX : to Host Virtual Investor Day on December 7, 2021
AQ
10/13MIMEDX : Net Health Agreement with MIMEDX Streamlines Complex Insurance Benefits Verificat..
PR
10/13Net Health Announces Agreement with MiMedx Group, Inc
CI
09/14MIMEDX : HC Wainwright Adjusts Price Target for MiMedx Group to $8.50 From $20, Maintains ..
MT
09/13US Stocks Start Week Mostly Higher; Blue Chips Lead While Nasdaq Lags
MT
09/13Health Care Stocks Still Adding to Afternoon Slide
MT
09/13Top Midday Decliners
MT
09/13Health Care Stocks Slipping Monday Afternoon
MT
09/13MIMEDX : Amniotic Tissue Failed to Meet Primary Endpoints in Two Trials; Shares Plunge
MT
More news
Analyst Recommendations on MIMEDX GROUP, INC.
More recommendations
Financials (USD)
Sales 2021 251 M - -
Net income 2021 -30,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -24,2x
Yield 2021 -
Capitalization 740 M 740 M -
Capi. / Sales 2021 2,95x
Capi. / Sales 2022 2,73x
Nbr of Employees 735
Free-Float 96,4%
Chart MIMEDX GROUP, INC.
Duration : Period :
MiMedx Group, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MIMEDX GROUP, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 6,61 $
Average target price 16,17 $
Spread / Average Target 145%
EPS Revisions
Managers and Directors
Timothy R. Wright Chief Executive Officer & Director
Peter M. Carlson Chief Financial Officer
M. Kathleen Behrens Wilsey Chairman
David H. Mason Chief Medical Officer
Robert Benjamin Stein Executive Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
MIMEDX GROUP, INC.-22.80%740
MODERNA, INC.230.95%139 557
GILEAD SCIENCES, INC.16.25%84 921
BIONTECH SE258.67%70 618
WUXI APPTEC CO., LTD.23.63%64 231
REGENERON PHARMACEUTICALS22.57%61 565